https://acadia.com/media/news-releases/acadia-pharmaceuticals-and-neuren-pharmaceuticals-announce-exclusive-license-agreement-for-the-north-american-development-and-commercialization-of-trofinetide-in-rett-syndrome/
p2 trials had been released. They stepped in to fund p3 and get exclusive licensing deal.
p2 has get dropped first and has to be good, before any deal. Wouldn't make any sense otherwise.
- Forums
- ASX - By Stock
- BIT
- Results to Seal a Deal
Results to Seal a Deal, page-88
-
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
0.001(2.70%) |
Mkt cap ! $34.28M |
Open | High | Low | Value | Volume |
3.7¢ | 4.0¢ | 3.7¢ | $68.85K | 1.794M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 349950 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 0.037 |
5 | 415000 | 0.036 |
5 | 724214 | 0.035 |
2 | 106000 | 0.033 |
3 | 91250 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 349950 | 3 |
0.041 | 144000 | 2 |
0.042 | 117600 | 1 |
0.043 | 102000 | 1 |
0.045 | 120000 | 1 |
Last trade - 15.10pm 28/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online